# Med 247 Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/med-247-co

- Industry: Healthcare IT
- Headquarters: Hanoi, Vietnam
- Website: www.med247.vn
- Total disclosed funding: $4.8M
- Latest round: Series A (Apr 4, 2022)
- Investors on record: 7

## About

Med 247 Co., Ltd is a health technology company based in Vietnam, focusing on innovative solutions for patient care management and enhancing healthcare delivery through digital platforms.Founded in 2019 in Hanoi, Vietnam, Med 247 Co., Ltd specializes in health technology solutions, particularly in managing patient care. The company has successfully completed 4 deals, with its most recent being a Series A funding round in April 2022, raising USD 4.17 mn led by Altara Ventures. The founders, Thao Nguyen and Tuan Truong, have set the foundation for a company that aims to improve healthcare accessibility in the region.Med247 specializes in the development and provision of health technology solutions, primarily offering a comprehensive platform designed for managing patient care and enhancing healthcare delivery. Their core products include electronic health records (EHR), telemedicine solutions, and patient engagement tools, addressing critical challenges in healthcare such as accessibility and efficiency. Med247's services cater to various stakeholders in the healthcare ecosystem including hospitals, clinics, and individual practitioners, extending their market reach across Southeast Asia.In the most recent fiscal year of 2023, Med247 reported revenue of USD 1,212,755.4, with an EBITDA of USD -1,174,061.9, indicating ongoing investments in growth and development.Following a successful Series A funding round on April 4, 2022, where Med 247 raised USD 4.5 mn, the company plans to utilize this funding to expand its family clinic network across Vietnam, establish a training academy for healthcare professionals, and accelerate research and development efforts. The company currently supports 50,000 active users and is focusing on expanding its services to new geographic markets in Southeast Asia to meet increasing demand for its health technology solutions.

## Funding rounds

- Series A, Apr 4, 2022, $4.2M — Pavilion Capital, Altara Ventures, East Ventures, Venturra Capital, MiRXES
- Series A, Aug 3, 2021, $0.3M — KK Fund
- Seed, Jun 13, 2020, $0.3M — KK Fund, Kembangan Holdings Ltd.

## Investors

- KK Fund (https://capitalatlas.ai/funds/kk-fund) — Seed, Series A
- Kembangan Holdings Ltd. — Seed
- Pavilion Capital — Series A
- Altara Ventures (https://capitalatlas.ai/funds/altara-ventures) — Series A
- East Ventures (https://capitalatlas.ai/funds/east-ventures) — Series A
- Venturra Capital (https://capitalatlas.ai/funds/venturra-capital) — Series A
- MiRXES — Series A